Lupus Capital plc Stock
Your prediction
Pros and Cons of Lupus Capital plc in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Lupus Capital plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Lupus Capital plc | - | - | - | - | - | - | - |
| Sig plc | - | 1.020% | 8.791% | -53.302% | -54.587% | -70.359% | -71.682% |
| James Halstead plc | 0.680% | -3.311% | 0.000% | -32.407% | -27.723% | -30.476% | -72.031% |
| Polypipe Group(wi) | 0.550% | 0.000% | -8.458% | -22.689% | -20.000% | 9.524% | -25.581% |
News
Quanex Reports 77% Sales Surge
Quanex Building Products (NYSE:NX) reported third-quarter 2025 earnings on September 4, 2025, with net sales of $495.3 million, up 77% year-over-year, and adjusted EBITDA of $70.3 million, up 67.2%
